aspirin has been researched along with Myotonic Dystrophy in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with aspirin reduced the mean integrated ACTH response to naloxone by 33% (P < 0." | 5.29 | Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy. ( Crosbie, GV; Grice, JE; Hockings, GI; Jackson, AJ; Jackson, RV; Torpy, DJ; Walters, MM, 1994) |
| "Pretreatment with aspirin reduced the mean integrated ACTH response to naloxone by 33% (P < 0." | 1.29 | Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy. ( Crosbie, GV; Grice, JE; Hockings, GI; Jackson, AJ; Jackson, RV; Torpy, DJ; Walters, MM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaulieu, D | 1 |
| Thebault, P | 1 |
| Pelletier, R | 1 |
| Chapdelaine, P | 1 |
| Tarnopolsky, M | 1 |
| Furling, D | 1 |
| Puymirat, J | 1 |
| NUTTALL, FQ | 1 |
| DOE, RP | 1 |
| Hockings, GI | 1 |
| Jackson, RV | 1 |
| Grice, JE | 1 |
| Crosbie, GV | 1 |
| Walters, MM | 1 |
| Torpy, DJ | 1 |
| Jackson, AJ | 1 |
3 other studies available for aspirin and Myotonic Dystrophy
| Article | Year |
|---|---|
Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy.
Topics: Aspirin; Calcium; Cell Differentiation; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Hu | 2012 |
THE ACHILLES REFLEX IN THYROID DISORDERS; A CRITICAL EVALUATION.
Topics: Achilles Tendon; Adrenocorticotropic Hormone; Aging; Anemia; Anemia, Pernicious; Aspirin; Cold Tempe | 1964 |
Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy.
Topics: Adrenocorticotropic Hormone; Adult; Aspirin; Chromatography, High Pressure Liquid; Female; Humans; H | 1994 |